FY2022 Financial Results Presentation
Executive Officer CFO
Richard P. Kincaid

Descriptions of future events, etc. in this document include Healios’
assumptions, prospects, etc. based on information which could be
acquired at the time this document was presented. For this reason,
actual performance, development progress, etc. may differ from those
described in this document according to the outcome of R&D in the
future, the actions of regulatory authorities, etc. in the future, and
uncertain/pending factors as of this point.
Also, this document contains information on regenerative medicine
and medical equipment that are currently under development or
already on the market. Such information is not intended for promoting
advertising or providing medical advice.